Venture capital firm Frazier Healthcare Partners promoted Kent Berkley and Ryan Lucero to Principal, and Jennifer Martin and Carol Eckert to Vice President.
The promotions of Berkley and Lucero expand the Principal group on the Growth Buyout IP team to four, as they join Christina Miller Reszka and Phil Zaorski.
Berkley joined Frazier in 2016 as a Vice President and is on the IP team for several of Frazier’s portfolio companies including Matrix Medical Network, Parata and Caravel Autism Health. Before coming to Frazier, Berkley spent four years with The Edgewater Funds where he focused on leveraged buyout and growth equity investments in the healthcare, industrial and business services industries. Prior to Edgewater, Berkley was an Associate with CIVC Partners and worked for Dresner Partners and Lehman Brothers.
Lucero joined Frazier in 2016 as a Vice President and serves on the boards of MedData, EPTAM and United Digestive and is on the IP team for several portfolio companies including PCI. Before joining Frazier, Lucero spent five years with Kohlberg & Company where he focused on leveraged buyout and growth equity investments. Previously, Lucero worked for JPMorgan Chase & Co. and was also a member of the investment team for the Troubled Asset Relief Program (TARP) of the U.S. Department of the Treasury in Washington, DC.
Martin – Vice President of Finance – joined Frazier in 2015 in the firm’s accounting, treasury and finance group. She has extensive experience in hedge and private equity fund activities, including multiple fund structures and standard control practices, and has advised numerous asset managers in the implementation of new financial accounting and disclosure requirements. Prior to joining Frazier, Martin was the CFO of Red Mountain Capital Partners, a hedge fund manager located in Los Angeles. She was also previously a manager with PricewaterhouseCoopers in the Asset Management audit practice.
Eckert – Vice President of Investor Relations – joined Frazier in 2016 as Director of Investor Relations, heading up IR, marketing and communications for the Growth Buyout team. She helped lead the latest fundraise, FHGB IX, which closed in April of 2018. Eckert came to Frazier after several years in private accounting consulting. She began her career in public accounting at Deloitte in Seattle, and then as Director of Accounting at Immunex Corporation.
Founded in 1991, Frazier Healthcare Partners is a provider of growth and venture capital to healthcare companies. With nearly $4.8 billion in total capital raised, the firm has invested in more than 200 companies with investments ranging from company creation and venture capital to buyouts of profitable lower-middle market companies. The firm’s Growth Buyout team invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. Frazier has offices in Seattle, Wash., and Menlo Park, Calif., and invests broadly across the U.S., Canada and Europe.